Frontiers in Cardiovascular Medicine (Aug 2023)

Case Report: A rare homozygous patient affected by TTR systemic amyloidosis with a prominent heart involvement

  • Emanuele Micaglio,
  • Gloria Santangelo,
  • Silvia Moscardelli,
  • Daniela Rusconi,
  • Francesco Musca,
  • Alessandro Verde,
  • Laura Campiglio,
  • Francesca Bursi,
  • Marco Guazzi

DOI
https://doi.org/10.3389/fcvm.2023.1164916
Journal volume & issue
Vol. 10

Abstract

Read online

Hereditary transthyretin amyloidosis is a severe, adult-onset autosomal dominant inherited systemic disease predominantly affecting the peripheral and autonomic nervous system, heart, kidney, and the eyes. We present a case of a Caucasian 65-year-old man with cardiac amyloidosis and the homozygous mutation Val142Ile (classically, Val122Ile) in the transthyretin gene. We provide a genotype-phenotype correlation regarding the genetic status of both heterozygous and homozygous individuals and their clinical conditions at the time of genetic testing.

Keywords